产科和妇科手术后出院阿片类药物消耗、剩余和处理:一项系统综述
该系统综述纳入2000至2021年发表的10项研究(9项队列研究和1项随机临床试验),评估产科和妇科手术后阿片类药物的消耗、剩余和处理模式。结果显示,妇科手术患者阿片类药物消耗量高于剖宫产,腹式子宫切除术消耗和剩余最多,平均77.5%的剩余阿片类药物未被处理或保留,仅20%通过处理项目丢弃。作者推荐进行围手术期阿片类药物相关咨询和教育,并考虑减少医生处方的策略。
要点
- 剖宫产术后消耗21.8 OME,阴式子宫切除术55.7 OME,腹式子宫切除术105.8 OME,腹腔镜子宫切除术89.0 OME。
- 阴式、腹式和腹腔镜子宫切除术组剩余阿片类药物分别为67.6 OME、115.5 OME和95.3 OME。
- 平均77.5%的剩余阿片类药物未被处理或保留,仅20%通过处理项目丢弃。
核心结论
- 与剖宫产相比,妇科手术患者消耗大量阿片类药物,尤其是腹式子宫切除术后。
- 腹式子宫切除术也与大量剩余阿片类药物相关。
- 大多数患者未使用全部处方阿片类药物,并保留未使用的药物或不确定如何处理。
- 作者推荐对患者进行围手术期阿片类药物特异性咨询和教育,包括阿片类药物消耗、未使用药物的潜在危害和正确处理。
- 应考虑减少医生阿片类药物处方的策略。
研究设计与样本
- 系统综述,检索PubMed、Embase、Cochrane Library和MEDLINE等电子数据库,纳入2000年至2021年发表的随机试验、队列研究、病例对照研究和临床试验。
- 纳入标准为与产科和/或妇科手术相关的阿片类药物消耗、剩余和处理模式的研究,排除综述文章、会议摘要、病例系列和病例报告以及无法获取全文的摘要。
- 共纳入10项研究:9项队列研究和1项随机临床试验,研究人群为产科和/或妇科手术后被处方阿片类药物的女性。
- 使用纽卡斯尔-渥太华量表评估队列研究的偏倚风险,使用美国国家心肺血液研究所对照干预研究质量评估工具评估临床试验。
主要发现
- 剖宫产术后出院阿片类药物消耗总量为21.8口服吗啡当量(OME)。
- 阴式子宫切除术术后消耗55.7 OME,腹式子宫切除术105.8 OME,腹腔镜子宫切除术89.0 OME。
- 阴式、腹式和腹腔镜子宫切除术组剩余阿片类药物分别为67.6 OME、115.5 OME和95.3 OME。
- 平均77.5%的剩余阿片类药物未被处理或保留,仅20%通过处理项目丢弃。
- 5项研究质量评为fair,其余评为good。
临床怎么用
- 作者推荐对患者进行围手术期阿片类药物特异性咨询和教育,内容包括阿片类药物消耗、未使用药物的潜在危害和正确处理。
- 作者认为应考虑减少医生阿片类药物处方的策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To perform a systematic review on consumption, leftover, and disposal of prescribed opioids after surgery in obstetrics and gynecology (The International Prospective Register of Systematic Reviews ID 249856). DATA SOURCES: Electronic database searches on PubMed, Embase, Cochrane Library, and MEDLINE and other search methods including all studies published between the years 2000 and 2021 were used. METHODS OF STUDY SELECTION: We included all randomized trials, cohorts, case-control studies, and clinical trials. The search was limited to studies related to obstetrics and gynecology. Studies that pertained to opioid consumption, leftover, and disposal patterns were selected. We excluded review articles, meeting abstracts, case series and case reports, and abstracts without access to full texts. The search was limited to trials in humans and published in English language. Study population included women who were prescribed opioids after obstetric and/or gynecologic procedures. Information on opioid consumption, leftover, and disposal patterns were extracted and compared among different procedures. Potential risk of bias was evaluated using the Newcastle-Ottawa Scale for cohort studies and the National Heart, Lung, and Blood Institute Study Quality Assessment Tool of Controlled Interventional Studies for clinical trial. TABULATION, INTEGRATION, AND RESULTS: Of 2343 articles, 10 were used in the analysis: 9 cohorts and 1 randomized clinical trial. We found that among patients who underwent obstetric and gynecologic procedures, a considerable number of opioids are unused. The total number of consumed opioids after discharge in patients who underwent cesarean delivery was 21.8 oral morphine equivalent (OME); vaginal hysterectomy, 55.7 OME; abdominal hysterectomy, 105.8 OME; and laparoscopic hysterectomy, 89.0 OME. The number of opioids leftover in the vaginal, abdominal, and laparoscopic hysterectomy groups was 67.6 OME, 115.5 OME, and 95.3 OME, respectively. On average, 77.5% of leftover opioids were not disposed/kept, whereas only 20% discarded their medication through a disposal program. Five studies were deemed to have fair quality, and the rest were rated as good quality. CONCLUSION: Compared with those after cesarean delivery, patients undergoing gynecologic procedures consumed a large number of opioids, especially after abdominal hysterectomies. Abdominal hysterectomy was also associated with a high number of opioids leftover. Most patients did not use the entire prescribed opioids and were either keeping their unused opioids or unsure about what to do with them. We recommend perioperative opioid-specific counseling and education on opioid consumption, potential hazards of unused medication, and proper disposal for patients. Strategies to reduce opioids prescription by physicians should be considered.
引用
- Raina J, Costello C, Suarthana E, et al. Postoperative Discharge Opioid Consumption, Leftover, and Disposal after Obstetric and Gynecologic Procedures: A Systematic Review. J Minim Invasive Gynecol. 2022. PMID: 35513302. doi:10.1016/j.jmig.2022.04.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。